SCHEMBL5375174

SCHEMBL5375174

Cc1ccc(S(=O)(=O)Nc2ccc3nc(-c4ccccc4)sc3c2)cc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.60
HPGD P15428 7/20 0.60
SMN1; SMN2 Q16637 11/20 0.59
LMNA P02545 11/20 0.59
HTT P42858 7/20 0.59
PKM P14618 2/20 0.59
NOD2 Q9HC29 1/20 0.59
MAPT P10636 7/20 0.57
GAA P10253 5/20 0.57
KDM4E B2RXH2 5/20 0.57
GLA P06280 4/20 0.57
RORC P51449 4/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
NFKB1 P19838 2/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
HSP90AA1 P07900 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373408 0.91 ALDH1A1 (0.57) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5375367 0.90 ALDH1A1 (0.60) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5380411 0.89 MAPT (0.74) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5369912 0.81 ALDH1A1 (0.70) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5382225 0.80 MAPT (0.71) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5371897 0.79 ALDH1A1 (0.70) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5377046 0.79 PTPN5 (0.61) ALDH1A1HPGDLMNAHTTMAPT
SCHEMBL5376843 0.78 ALDH1A1 (0.70) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5373585 0.78 ALDH1A1 (0.56) ALDH1A1HPGDSMN1; SMN2LMNAHTT
SCHEMBL5373258 0.78 ALDH1A1 (0.55) ALDH1A1HPGDSMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885HPGD 724/4885SMN1; SMN2 3404/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD ALDH1A1 2752/4885HPGD 696/4885SMN1; SMN2 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.